Respiratory follow‐up after hospitalization for COVID‐19: Who and when?

Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate and long-term survivors' outcome remains largely unknown. Lungs are the main COVID-19 target organ, and 5-10% patients progress to critical disease including acute respiratory distress sy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European Journal of Clinical Investigation 2021-08, Vol.51 (8), p.e13603-n/a, Article 13603
Hauptverfasser:	Riou, Marianne, MarcoT, Christophe, Oulehri, Walid, Enache, Irina, Pistea, Cristina, Chatron, Eva, Labani, Aissam, Geny, Bernard, Ohana, Mickael, De Blay, Frederic, Kessler, Romain, Charloux, Anne
Format:	Artikel
Sprache:	eng
Schlagworte:	Computer Science COVID-19 General & Internal Medicine Image Processing Life Sciences & Biomedicine Medicine, General & Internal Medicine, Research & Experimental Research & Experimental Medicine Research Letter respiratory function respiratory outcome respiratory sequelae Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate and long-term survivors' outcome remains largely unknown. Lungs are the main COVID-19 target organ, and 5-10% patients progress to critical disease including acute respiratory distress syndrome (ARDS) [1]. Pulmonary function tests (PFT) performed at discharge from hospital showed that >80% of severe COVID-19 patients had lung function impairment [2].
ISSN:	0014-2972 1365-2362
DOI:	10.1111/eci.13603